Pain Control Options for Lupus

Foundation Therapy (All Patients)

• Hydroxychloroquine is the cornerstone of pain management at a dose not exceeding 5 mg/kg real body weight, as it reduces disease activity, prevents flares, and improves survival 2
• For lupus-related pain, hydroxychloroquine should be the foundation of therapy for all patients, combined with NSAIDs for acute musculoskeletal symptoms and low-dose glucocorticoids for persistent pain, with the goal of minimizing chronic steroid exposure 1, 2

First-Line Pain Control for Musculoskeletal Symptoms

• NSAIDs are appropriate for intermittent joint pain and serositis, with up to 80% of lupus patients receiving them for musculoskeletal symptoms 1

Glucocorticoid Use for Pain Control

• For acute flares with severe pain: Intravenous methylprednisolone pulses provide immediate therapeutic effect and enable lower starting doses of oral glucocorticoids 2
• For chronic pain management: Glucocorticoids should be minimized to less than 7.5 mg/day prednisone equivalent and withdrawn when possible to prevent organ damage 2

Organ-Specific Pain Management

Serositis (Pericarditis/Pleuritis)

• Colchicine combined with standard therapy decreases pericarditis recurrence rate 3

Cutaneous Pain

• Topical glucocorticoids are the mainstay for localized cutaneous manifestations 4
• For refractory cutaneous disease causing pain, mycophenolate mofetil is effective 4

Critical Monitoring Requirements

• Assess disease activity at each visit using validated indices (BILAG, ECLAM, or SLEDAI) 1, 2
• Monitor anti-dsDNA, C3, C4, complete blood count, creatinine, proteinuria, and urine sediment 2
• Patients on long-term glucocorticoids require calcium and vitamin D supplementation to prevent bone loss 1, 2